Home > Boards > US Listed > Biotechs >

Medicenna Therapeutics Corp. (MDNA)

MDNA RSS Feed 		Add MDNA Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board: 
Last Post: 12/26/2020 4:16:27 PM - Followers: 1 - Board type: Free - Posts Today: 0

Here is a very attractive and brutally undervalued canadian company called Medicenna (MDNA.TO) which is listed since March thats why its also undicovered . This Cancer Play has a Phase 2 trial in recurrent Glioblastoma ongoing a $650 Million Market , they expect to complete enrollment by year end and to report results in early Q1 2018 . If the results are positive then they can file for accelerated approval in 2H 2018 and this makes this company with a terrible low valuation of only C$ 36 Million a super attractive opportunity which has 10 bagger potential easily on positive phase 2 results in Q1 2018 and FDA approval .Please do your own DD and realize the mega potential .GL


Medicenna Therapeutics (MDNA.TO)

Market Cap C$36 Million
Cash : C$ 20 Million << enough untill Q1 2019
Price : $1.50

Shares Out: 24.3 Million ( 15.5 Million shares held by Insider alone )


Medicenna Therapeutics (TSXV: MDNA) CEO: Our Drug Has Potential for Phase 2 Approval
https://smallcappower.com/videos/companies-to-watch/medicenna-therapeutics-tsxv-mdna/



New Presentation
http://s21.q4cdn.com/710416940/files/doc_presentations/2017/Medicenna-Corporate-Presentation-Q3-2017.pdf


Fact Sheet
http://s21.q4cdn.com/710416940/files/doc_downloads/fact_sheet/Medicenna-FS-Q1-2017-v2.pdf

Insider Ownership :

Aries Biologics, Inc. 5 500 000
Rosemina Merchant 5 050 000
Fahar Merchant 5 050 000
Elizabeth Williams 5 300
Chandrakant J. Panchal, PhD 1 000
Trevor P. Wong-Chor 714


\


\




 
MDNA
Current Price
Volume:
Bid Ask Day's Range
MDNA Detailed Quote
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
MDNA News: Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) 03/04/2021 07:30:43 AM
MDNA News: Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) 02/22/2021 07:15:42 AM
MDNA News: Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) 02/17/2021 09:02:26 AM
MDNA News: Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) 02/12/2021 10:55:15 AM
MDNA News: Medicenna Therapeutics reports FQ3 results 02/12/2021 07:16:36 AM
PostSubject
#7   Going much higher. Double digits in EagleD 12/26/20 04:16:27 PM
#6   Nice after hours action, Just made 20,000. EagleD 12/17/20 07:21:06 PM
#5   FDA meeting Tuesday. Seems like we'll know EagleD 09/26/20 08:48:09 PM
#4   This is my largest holding -- ever. EagleD 09/14/20 06:30:11 PM
#3   MDNA moved from the OTC to the Nasdaq: Renee 08/24/20 10:33:12 AM
#2   Just stumbled onto this co.. was doing some tykundegex 01/03/19 05:01:26 PM
#1   Nice move yesterday .. BioSpecialist 09/21/17 10:27:25 AM
PostSubject
© 2021 InvestorsHub.com, Inc.
Consent Preferences




Ticker News is disabled